Purchase Order 75N91023K00023
Award Date 7/28/23
Potential Completion Date 8/9/23
Potential Value $12K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Great Britain, United Kingdom
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- UK Biobank Limited has been awarded a $13,500 purchase order by the National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services, to provide laboratory and testing services. The firm fixed price contract runs from December 2023 through March 2026 and will be performed by UK Biobank in Great Britain. No additional details were provided on the original solicitation or work scope. The award does not appear to be associated with a...
- This is a $12,120 firm fixed-price purchase order awarded by the National Cancer Institute, part of the National Institutes of Health, to UK Biobank Limited, a non-profit organization. The contract provides UK Biobank Limited's large-scale biomedical database containing de-identified genetic, lifestyle, and health information from over 500,000 UK participants as a research resource for approved scientific researchers to analyze. The award, with a completion date of February 6, 2026,...
- This federal contract award, valued at $11,550.24, was issued by the National Human Genome Research Institute, a civilian agency within the National Institutes of Health (NIH), to UK Biobank Limited, a non-profit organization based in the United Kingdom. The contract is for a 36-month extension to provide Tier 3 level access to UK Biobank's large-scale biomedical database, which contains de-identified genetic, lifestyle, and health information from over 500,000 participants in the UK. This...
- This firm fixed-price purchase order contract, valued at $12,369.70, was awarded by the National Institute on Aging (NIA), a component of the National Institutes of Health (NIH), to UK Biobank Limited, a non-profit organization. The contract provides Tier 3 access to UK Biobank's large-scale, de-identified biomedical database containing genetic, lifestyle, and health information from over 500,000 participants in the United Kingdom. This data access supports biomedical research projects across...
- This firm fixed-price purchase order contract was awarded by the National Eye Institute (NEI), a component of the National Institutes of Health (NIH), to UK Biobank Limited, a non-profit organization. The $11,630.34 contract provides access to UK Biobank's large-scale biomedical database containing genetic, lifestyle, and health information from over 500,000 UK participants. This biobank serves as a research resource for approved scientific studies, and the contract facilitates projects...
- The National Institute of Child Health and Human Development (NICHD) awarded a $12,000 firm fixed-price purchase order to UK Biobank LIMITED on September 23, 2025, for Tier 3 access to the organization's comprehensive biomedical research datasets. The contract, which carries no set-aside designation, is severable and will conclude by September 22, 2026. UK Biobank LIMITED, a non-profit organization registered in Stockport, United Kingdom, maintains one of the world's largest biobanks with...
- This purchase order awards UK Biobank Limited $12,934.99 to provide Tier 3 access fees under a potential value of the same amount. As a non-profit organization, the contractor will deliver its standard biobank datasets and related laboratory and testing services to the Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute in Bethesda, Maryland by November 14, 2024. The firm fixed price contract vehicle was awarded on November 15, 2023...
- The National Heart Lung and Blood Institute (NHLBI), a civilian component of the National Institutes of Health, awarded a $10,330.40 firm fixed-price purchase order to UK Biobank LIMITED for Tier 2 data access fees under a 36-month extension. The contract, which carries no set-aside designation, is scheduled for ultimate completion on December 17, 2025, with an award date of July 9, 2025. UK Biobank LIMITED, a non-profit organization registered in SAM.gov and based in Stockport, United...
- The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a firm fixed-price purchase order valued at $14,320 to UK Biobank LIMITED for access to individual-level genomic, metabolomic, proteomic, imaging, and linked health-record data. The contract, which carries no set-aside designation, was awarded on September 23, 2025, with an ultimate completion date of September 22, 2026. Performance will occur in Stockport, United Kingdom, where UK Biobank LIMITED maintains and manages its...
- This firm fixed price contract was awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to the United Kingdom's Department of Health, doing business as the Medicines & Healthcare Products Regulatory Agency. The $185,877.28 contract provides the NCI's Division of Cancer Epidemiology and Genetics (DCEG) with a one-year license to access the Clinical Practice Research Datalink (CPRD) medical records database, which contains...